Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 38,537 of its own ordinary shares between June 9 and June 12, 2026, under a program announced on June 9. The total cost of the repurchases amounted to €954,808.90, reflecting an average purchase price of €24.78 per share.
Key figures
- Average price eur
- 24.7764
- Shares repurchased
- 38537
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.